Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1993 2
1994 3
1995 3
1996 3
1997 6
1998 3
1999 8
2000 20
2001 27
2002 38
2003 30
2004 19
2005 14
2006 18
2007 21
2008 21
2009 20
2010 19
2011 27
2012 29
2013 32
2014 26
2015 28
2016 27
2017 19
2018 23
2019 18
2020 21
2021 21
2022 18
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Results by year

Filters applied: . Clear all
Page 1
[Immunogenicity of biosimilars].
van Aerts LA, Franken AA, Leufkens HG. van Aerts LA, et al. Among authors: leufkens hg. Ned Tijdschr Geneeskd. 2016;160:D888. Ned Tijdschr Geneeskd. 2016. PMID: 28000573 Review. Dutch.
Emergent treatments for β-thalassemia and orphan drug legislations.
Costa E, Cappellini MD, Rivella S, Chilin A, Alessi E, Riccaboni M, Leufkens HGM, Luzzatto L. Costa E, et al. Among authors: leufkens hgm. Drug Discov Today. 2022 Nov;27(11):103342. doi: 10.1016/j.drudis.2022.103342. Epub 2022 Sep 1. Drug Discov Today. 2022. PMID: 36058507 Free article. Review.
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
Tetteh RA, Yankey BA, Nartey ET, Lartey M, Leufkens HG, Dodoo AN. Tetteh RA, et al. Among authors: leufkens hg. Drug Saf. 2017 Apr;40(4):273-283. doi: 10.1007/s40264-017-0505-6. Drug Saf. 2017. PMID: 28130774 Free PMC article. Review.
Four scenarios for the future of medicines and social policy in 2030.
Leufkens HG, Kusynová Z, Aitken M, Hoekman J, Stolk P, Klein K, Mantel-Teeuwisse AK. Leufkens HG, et al. Drug Discov Today. 2022 Aug;27(8):2252-2260. doi: 10.1016/j.drudis.2022.03.018. Epub 2022 Mar 29. Drug Discov Today. 2022. PMID: 35364271 Free article. Review.
Medicine shortages: impact behind numbers.
Postma DJ, Notenboom K, De Smet PAGM, Leufkens HGM, Mantel-Teeuwisse AK. Postma DJ, et al. Among authors: leufkens hgm. J Pharm Policy Pract. 2023 Mar 14;16(1):44. doi: 10.1186/s40545-023-00548-x. J Pharm Policy Pract. 2023. PMID: 36918981 Free PMC article.
Traceability of biologicals: present challenges in pharmacovigilance.
Vermeer NS, Spierings I, Mantel-Teeuwisse AK, Straus SM, Giezen TJ, Leufkens HG, Egberts TC, De Bruin ML. Vermeer NS, et al. Among authors: leufkens hg. Expert Opin Drug Saf. 2015 Jan;14(1):63-72. doi: 10.1517/14740338.2015.972362. Epub 2014 Nov 5. Expert Opin Drug Saf. 2015. PMID: 25369769 Review.
Switching TNFα inhibitors: Patterns and determinants.
Meijboom RW, Gardarsdottir H, Becker ML, de Groot MCH, Movig KLL, Kuijvenhoven J, Egberts TCG, Leufkens HGM, Giezen TJ. Meijboom RW, et al. Among authors: leufkens hgm. Pharmacol Res Perspect. 2021 Aug;9(4):e00843. doi: 10.1002/prp2.843. Pharmacol Res Perspect. 2021. PMID: 34302442 Free PMC article.
521 results